ZFF29 inhibitors are a class of chemical compounds that specifically target zinc finger protein family member 29 (ZFF29), a transcription factor that plays a critical role in regulating gene expression. Like other zinc finger proteins, ZFF29 contains zinc finger motifs, which are specialized structural domains that allow the protein to bind to specific DNA sequences. These motifs depend on the coordination of zinc ions to maintain their structural integrity, which is essential for the protein's ability to recognize and interact with particular DNA regions. ZFF29 is involved in controlling the transcription of various genes, influencing a range of cellular processes. Inhibitors of ZFF29 disrupt this interaction with DNA by interfering with the protein's structural motifs or by blocking its ability to bind to its target DNA sequences, leading to altered gene regulation.
The mechanisms by which ZFF29 inhibitors function vary based on their chemical composition. One common approach involves chelating the zinc ions that are required to maintain the structural stability of the zinc finger motifs. By binding to these zinc ions, the inhibitors cause the zinc finger domains to lose their proper conformation, preventing ZFF29 from effectively binding to DNA. Without this interaction, ZFF29 is unable to regulate gene transcription, which disrupts the cellular pathways it normally controls. Other inhibitors may interfere with the protein's ability to form necessary protein-protein interactions, which are crucial for the formation of transcriptional complexes. By inhibiting these interactions, the inhibitors further impair the regulatory function of ZFF29. Research into ZFF29 inhibitors provides valuable insights into the broader role of zinc finger proteins in gene regulation, helping to elucidate the complex mechanisms that govern transcriptional control and cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits ZNF367 expression by intercalating into DNA, preventing the transcription of ZNF367-regulated genes, thereby reducing its expression levels. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits ZNF367 expression by blocking protein synthesis, leading to reduced levels of newly synthesized ZNF367 and impacting its regulatory functions. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Puromycin inhibits ZNF367 expression by causing premature chain termination during protein synthesis, leading to reduced levels of functional ZNF367 protein. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin inhibits ZNF367 expression by intercalating into DNA, disrupting the transcription of ZNF367-regulated genes, leading to decreased ZNF367 expression. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Cisplatin inhibits ZNF367 expression by forming DNA adducts, interfering with the binding of transcription factors to ZNF367-regulated genes, thus reducing its expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
5-Fluorouracil inhibits ZNF367 expression by interfering with DNA synthesis, disrupting the transcription of ZNF367-regulated genes, leading to reduced ZNF367 expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits ZNF367 expression by stabilizing the cleavable complex formed by topoisomerase I, leading to DNA damage and reduced ZNF367 expression. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Mitomycin C inhibits ZNF367 expression by forming DNA adducts, interfering with the binding of transcription factors to ZNF367-regulated genes, thus reducing its expression. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $270.00 | 5 | |
Bleomycin inhibits ZNF367 expression by causing DNA strand breaks and oxidative damage, leading to reduced ZNF367 expression. | ||||||
Idarubicin | 58957-92-9 | sc-507346 | 10 mg | $180.00 | ||
Idarubicin inhibits ZNF367 expression by intercalating into DNA, disrupting the transcription of ZNF367-regulated genes, leading to decreased ZNF367 expression. | ||||||